Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
Japan
· Delayed Price · Currency is JPY 1,337.00
-64.00 (-4.57%)
Apr 3, 2025, 2:45 PM JST
TYO:2395 Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | - | 6,974 | 7,759 | 8,183 | 4,175 | 3,062 | Upgrade
|
| Depreciation & Amortization | - | 1,867 | 1,600 | 1,177 | 1,187 | 1,229 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 84 | 56 | 246 | 642 | 58 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 31 | 1,321 | -1,058 | -1,173 | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | -2,751 | -2,489 | -1,439 | -846 | -888 | Upgrade
|
| Other Operating Activities | - | 1,048 | 256 | -90 | -66 | -136 | Upgrade
|
| Change in Accounts Receivable | - | -956 | -937 | -480 | -343 | -619 | Upgrade
|
| Change in Inventory | - | -5,003 | -968 | -371 | -71 | -445 | Upgrade
|
| Change in Accounts Payable | - | -177 | -268 | -36 | -24 | 82 | Upgrade
|
| Change in Other Net Operating Assets | - | 989 | -2,326 | -180 | 1,265 | 675 | Upgrade
|
| Operating Cash Flow | - | 2,106 | 4,004 | 5,952 | 4,746 | 3,018 | Upgrade
|
| Operating Cash Flow Growth | - | -47.40% | -32.73% | 25.41% | 57.26% | 4.36% | Upgrade
|
| Capital Expenditures | - | -8,582 | -4,838 | -1,542 | -1,067 | -1,148 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 5 | 11 | - | 1 | 1 | Upgrade
|
| Cash Acquisitions | - | -883 | -1,937 | 58 | - | -4 | Upgrade
|
| Divestitures | - | - | - | 1,142 | 1,242 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -22 | -116 | -71 | -50 | -82 | Upgrade
|
| Investment in Securities | - | 2,625 | 1,018 | -4,194 | -804 | -790 | Upgrade
|
| Other Investing Activities | - | -50 | -68 | 2 | -1 | -10 | Upgrade
|
| Investing Cash Flow | - | -6,907 | -5,930 | -4,268 | -268 | -1,455 | Upgrade
|
| Short-Term Debt Issued | - | - | 4,083 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 17,700 | 10,300 | - | 4,540 | 9,060 | Upgrade
|
| Total Debt Issued | - | 17,700 | 14,383 | - | 4,540 | 9,060 | Upgrade
|
| Short-Term Debt Repaid | - | -3,903 | - | -6 | -2,000 | -5,920 | Upgrade
|
| Long-Term Debt Repaid | - | -6,231 | -5,469 | -3,492 | -4,598 | -4,167 | Upgrade
|
| Total Debt Repaid | - | -10,134 | -5,469 | -3,498 | -6,598 | -10,087 | Upgrade
|
| Net Debt Issued (Repaid) | - | 7,566 | 8,914 | -3,498 | -2,058 | -1,027 | Upgrade
|
| Dividends Paid | - | -2,073 | -2,485 | -827 | -207 | -123 | Upgrade
|
| Other Financing Activities | - | -175 | -163 | -586 | -206 | -299 | Upgrade
|
| Financing Cash Flow | - | 5,318 | 6,266 | -4,911 | -2,471 | -1,449 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 559 | 311 | 496 | 29 | -5 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 1 | -2 | - | - | -1 | Upgrade
|
| Net Cash Flow | - | 1,077 | 4,649 | -2,731 | 2,036 | 108 | Upgrade
|
| Free Cash Flow | - | -6,476 | -834 | 4,410 | 3,679 | 1,870 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 19.87% | 96.74% | 2.47% | Upgrade
|
| Free Cash Flow Margin | - | -24.48% | -3.32% | 24.85% | 24.35% | 12.84% | Upgrade
|
| Free Cash Flow Per Share | - | -155.56 | -20.03 | 105.93 | 88.37 | 44.92 | Upgrade
|
| Cash Interest Paid | - | 125 | 118 | 118 | 172 | 287 | Upgrade
|
| Cash Income Tax Paid | - | 1,223 | 1,437 | 1,014 | 479 | 82 | Upgrade
|
| Levered Free Cash Flow | - | -7,430 | -2,725 | 2,467 | 2,677 | 1,144 | Upgrade
|
| Unlevered Free Cash Flow | - | -7,344 | -2,647 | 2,546 | 2,792 | 1,291 | Upgrade
|
| Change in Net Working Capital | 98.55 | 3,208 | 2,571 | -359 | -1,141 | 101 | Upgrade
|
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.